Family · Pharmaceutical analytical standards
Ziprasidone
An atypical antipsychotic first approved in Sweden in 1998 and in the United States in 2001: it is used for schizophrenia and for manic and mixed episodes of bipolar disorder. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?It was first synthesised in 1987 at a research centre in Groton, Connecticut; chemically it is a structural analogue of risperidone, with a benzisothiazole group linked to a piperazine ring.
No product matches your search.
EDQM standards 4
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
